Oregon Health & Science University researchers are developing a promising new blood test that could provide a way to catch pancreatic cancer earlier in more patients.
The early screening is called the PAC-MANN test. Dr. Madappa Kundranda is with Banner MD Anderson Cancer Center.
“So this is one thing which requires a very small amount of blood. And blood draws, for the most part, are non-invasive, and the turnaround time is less than an hour," Kundranda said.
Kundranda says one of the reasons the disease is so deadly is because patients are usually in later stages by the time the cancer is detected. Larger scale studies still need to be done before the test can go to market.
Kundranda had a full interview with Arizona Horizon here.
More Health + Medicine News
-
The 9th Circuit Court of Appeals, in the unsigned order, said that the state is raising "serious questions" about the ability of a federal judge to take over health care in a prison system. -
Arizona has for a long time been one of the leading states for refugee resettlement, but now with the numbers cut so low, refugees in our state and the resettlement agencies that are built up to help them adjust are feeling the impact. -
Attorney General Kris Mayes filed a lawsuit, accusing TikTok of violating the state’s consumer protection laws. -
New data show a blood test was able to screen for several types of cancer, including some that currently don’t have any other screening tools. The study was published in the journal Nature Medicine and found the test was able to detect cancers including breast, lung, ovarian and more. -
An ASU professor and a Mayo Clinic neurologist have joined forces to light to sell "neuro-optimized" green light to help people suffering from migraines.
